Back to results
US 2026/0250668 A1Published application
Cytidine deaminases and methods of use in mapping modified cytosine nucleotides
AssigneeIllumina, Inc.
InventorGaetano Speciale
Life of this patent
Estimating the term…
Abstract
The present disclosure is concerned with proteins, methods, compositions, and kits for mapping of methylation status of nucleic acids. In one embodiment, proteins are provided that selectively act on certain modified cytosines of target nucleic acids and converts them to thymine. Also provided are compositions and kits that include one or more of the proteins and methods for using one or more of the proteins.
Claims30
A method for identifying methylated nucleotides comprising:
- providing a sample of DNA suspected of comprising at least one 5-methyl cytosine (5mC);
- contacting the sample with a cytidine deaminase;
- contacting the sample with an uracil-DNA glycosylase (UDG) to result in modified DNA;
- and
- processing the modified DNA to produce a sequencing library.
2 more elements
(canceled)
(canceled)
(canceled)
-15. (canceled)
(canceled)
(canceled)
(canceled)
-30. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.